tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CAPR Stock Latest News

Capricor Therapeutics to join Russell 2000, Russell 3000 indexes
The FlyCapricor Therapeutics to join Russell 2000, Russell 3000 indexes
26d ago
CAPR
Capricor Therapeutics Set to Join Russell 2000® and Russell 3000® Indexes
PremiumPress Releases
Capricor Therapeutics Set to Join Russell 2000® and Russell 3000® Indexes
26d ago
CAPR
Capricor Therapeutics Announces Long-Term Benefit of Deramiocel (CAP-1002) in Both Skeletal Muscle and Cardiac Function in the HOPE-2 OLE Study in Duchenne Muscular Dystrophy
PremiumPress Releases
Capricor Therapeutics Announces Long-Term Benefit of Deramiocel (CAP-1002) in Both Skeletal Muscle and Cardiac Function in the HOPE-2 OLE Study in Duchenne Muscular Dystrophy
29d ago
CAPR
Capricor announces three-year safety, efficacy results from HOPE-2 OLE study
PremiumThe Fly
Capricor announces three-year safety, efficacy results from HOPE-2 OLE study
29d ago
CAPR
CORRECTION: Capricor Therapeutics
PremiumPress Releases
CORRECTION: Capricor Therapeutics
1M ago
CAPR
Capricor Therapeutics announces Pre-BLA meeting for CAP-1002
PremiumThe FlyCapricor Therapeutics announces Pre-BLA meeting for CAP-1002
1M ago
CAPR
Capricor Therapeutics Announces for the Treatment of Duchenne Muscular Dystrophy
PremiumPress Releases
Capricor Therapeutics Announces for the Treatment of Duchenne Muscular Dystrophy
1M ago
CAPR
Capricor Therapeutics files $150M mixed securities shelf
PremiumThe Fly
Capricor Therapeutics files $150M mixed securities shelf
1M ago
CAPR
Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy with an Aim to Expedite BLA Pathway
PremiumPress Releases
Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy with an Aim to Expedite BLA Pathway
2M ago
CAPR
Capricor Therapeutics completes Type B meeting with FDA for CAP-1002 program
PremiumThe Fly
Capricor Therapeutics completes Type B meeting with FDA for CAP-1002 program
2M ago
CAPR
Capricor Therapeutics announces 3-year efficacy results from HOPE-2 OLE study
PremiumThe Fly
Capricor Therapeutics announces 3-year efficacy results from HOPE-2 OLE study
2M ago
CAPR
Capricor Therapeutics Announces Positive 3-Year Efficacy Results from HOPE-2 Open Label Extension Study of CAP-1002 in Duchenne Muscular Dystrophy
PremiumPress Releases
Capricor Therapeutics Announces Positive 3-Year Efficacy Results from HOPE-2 Open Label Extension Study of CAP-1002 in Duchenne Muscular Dystrophy
2M ago
CAPR
Capricor Therapeutics initiated with an Outperform at Oppenheimer
PremiumThe FlyCapricor Therapeutics initiated with an Outperform at Oppenheimer
2M ago
CAPR
Capricor Therapeutics price target raised to $25 from $24 at Ladenburg
PremiumThe Fly
Capricor Therapeutics price target raised to $25 from $24 at Ladenburg
2M ago
CAPR
Capricor Therapeutics reports Q1 EPS (31c), consensus (11c)
PremiumThe Fly
Capricor Therapeutics reports Q1 EPS (31c), consensus (11c)
3M ago
CAPR
Capricor Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
PremiumPress Releases
Capricor Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
3M ago
CAPR
Capricor Therapeutics reports Q1 EPS (31c), consensus (11c)
PremiumThe Fly
Capricor Therapeutics reports Q1 EPS (31c), consensus (11c)
3M ago
CAPR
CAPR Earnings this Week: How Will it Perform?
PremiumPre-Earnings
CAPR Earnings this Week: How Will it Perform?
3M ago
CAPR
Capricor Therapeutics to present exosome platform updates
PremiumThe Fly
Capricor Therapeutics to present exosome platform updates
3M ago
CAPR
Capricor Therapeutics to Present Exosome Platform Updates at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
PremiumPress ReleasesCapricor Therapeutics to Present Exosome Platform Updates at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
3M ago
CAPR
Capricor Therapeutics to Present at Upcoming Scientific and Medical Conferences
PremiumPress Releases
Capricor Therapeutics to Present at Upcoming Scientific and Medical Conferences
3M ago
CAPR
Capricor Therapeutics Updates on Duchenne Treatment Progress
PremiumCompany Announcements
Capricor Therapeutics Updates on Duchenne Treatment Progress
3M ago
8K
CAPR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >